SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells
文献类型：期刊论文
| 作者 | Cui, Lijing; Du, Xin; Zou, Waiyi; Ding, Ke; Pan, Jingxuan; Bu, Qiangui; Li, Juan |
| 刊名 | CANCER BIOLOGY & THERAPY
 |
| 出版日期 | 2014 |
| 卷号 | 15期号:7页码:951-962 |
| ISSN号 | 1538-4047 |
| 学科主题 | Oncology |
| 语种 | 英语 |
| 源URL | [http://ir.foo.ac.cn/handle/2SETSVCV/255]  |
| 专题 | 中国科学院广州生物医药与健康研究院 |
| 推荐引用方式 GB/T 7714 | Cui, Lijing,Du, Xin,Zou, Waiyi,et al. SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells[J]. CANCER BIOLOGY & THERAPY,2014,15(7):951-962. |
| APA | Cui, Lijing.,Du, Xin.,Zou, Waiyi.,Ding, Ke.,Pan, Jingxuan.,...&Li, Juan.(2014).SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells.CANCER BIOLOGY & THERAPY,15(7),951-962. |
| MLA | Cui, Lijing,et al."SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells".CANCER BIOLOGY & THERAPY 15.7(2014):951-962. |
入库方式： OAI收割
来源：广州生物医药与健康研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。